Lupin receives FDA approval for Fluocinonide Topical Solution
July 26, 2017 | Wednesday | News
It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses
Source: Pixabay
Pharma Major Lupin Limited recently announced that it has received final approval for its Fluocinonide Topical Solution USP, 0.05% from the United States Food and Drug Administration (FDA) to market a generic version of County Line Pharmaceuticals, LLC’s Fluocinonide Topical Solution USP, 0.05%.
Lupin’s Fluocinonide Topical Solution USP, 0.05% is AT rated generic equivalent of County Line Pharmaceuticals, LLC’s Fluocinonide Topical Solution USP, 0.05%.
It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
